Clinical Trial Update: A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults [Phase 3]

View source ↗

Summary

Phase 3 study of PXVX200 live oral cholera vaccine completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• PXVX200

Snippet

Sponsor: Bavarian Nordic | Conditions: Cholera | Phase 3 | Status: COMPLETED | Results posted: 2021-04-30